# Radiofrequency Ablation of Pulmonary Tumors Response Evaluation

> **NCT00690703** · PHASE2 · COMPLETED · sponsor: **Angiodynamics, Inc.** · enrollment: 106 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Pulmonary Metastases

## Interventions

- **DEVICE:** RF ablation (Rita Medical Systems Model 1500x)

## Key facts

- **NCT ID:** NCT00690703
- **Lead sponsor:** Angiodynamics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-12
- **Final completion:** 2007-12
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2008-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690703, "Radiofrequency Ablation of Pulmonary Tumors Response Evaluation". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00690703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*